Related references
Note: Only part of the references are listed.Gβγ mediates activation of Rho guanine nucleotide exchange factor ARHGEF17 that promotes metastatic lung cancer progression
Irving Garcia-Jimenez et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2022)
Activation of GPR55 attenuates cognitive impairment and neurotoxicity in a mouse model of Alzheimer's disease induced by Aβ1-42 through inhibiting RhoA/ROCK2 pathway
XiaoTong Xiang et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2022)
The effect of intra-striatal administration of GPR55 agonist (LPI) and antagonist (ML193) on sensorimotor and motor functions in a Parkinson's disease rat model
Iman Fatemi et al.
ACTA NEUROPSYCHIATRICA (2021)
GPR55 Receptor Activation by the N-Acyl Dopamine Family Lipids Induces Apoptosis in Cancer Cells via the Nitric Oxide Synthase (nNOS) Over-Stimulation
Mikhail G. Akimov et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Gene Expression Data Mining Reveals the Involvement of GPR55 and Its Endogenous Ligands in Immune Response, Cancer, and Differentiation
Artur Wnorowski et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Preclinical Investigation in Neuroprotective Effects of the GPR55 Ligand VCE-006.1 in Experimental Models of Parkinson's Disease and Amyotrophic Lateral Sclerosis
Sonia Burgaz et al.
MOLECULES (2021)
Blockade of GPR55 in dorsal periaqueductal gray produces anxiety-like behaviors and evocates defensive aggressive responses in alcohol-pre-exposed rats
Priscila Vazquez-Leon et al.
NEUROSCIENCE LETTERS (2021)
Cannabinoid receptor GPR55 activation blocks nicotine use disorder by regulation of AMPAR phosphorylation
Qingqing Liu et al.
PSYCHOPHARMACOLOGY (2021)
GPR55 in the brain and chronic neuropathic pain
Sabiha Armin et al.
BEHAVIOURAL BRAIN RESEARCH (2021)
Peptide targeting of lysophosphatidylinositol-sensing GPR55 for osteoclastogenesis tuning
Maria Giovanna Mosca et al.
CELL COMMUNICATION AND SIGNALING (2021)
Lysophosphatidylglucoside is a GPR55-mediated chemotactic molecule for human monocytes and macrophages
Xiaojia Li et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2021)
Expression of the putative cannabinoid receptor GPR55 is increased in endometrial carcinoma
Thangesweran Ayakannu et al.
HISTOCHEMISTRY AND CELL BIOLOGY (2021)
Cannabinoids in the landscape of cancer
Nagina Mangal et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2021)
Haematopoietic and cardiac GPR55 synchronize post-myocardial infarction remodelling
Sarah-Lena Puhl et al.
SCIENTIFIC REPORTS (2021)
The Endocannabinoid System: A Target for Cancer Treatment
Chiara Laezza et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
GPR119 Is a Potent Regulator of Human Sebocyte Biology
Arnold Markovics et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2020)
Lysolipid Chain Length Switches Agonistic to Antagonistic G Protein-Coupled Receptor Modulation
Adam T. Guy et al.
ACS CHEMICAL NEUROSCIENCE (2020)
Glycerophosphodiesterase 3 (GDE3) is a lysophosphatidylinositol-specific ectophospholipase C acting as an endocannabinoid signaling switch
Fabienne Briand-Mesange et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2020)
Formation of βTC3 and MIN6 Pseudoislets Changes the Expression Pattern of Gpr40, Gpr55, and Gpr119 Receptors and Improves Lysophosphatidylcholines-Potentiated Glucose-Stimulated Insulin Secretion
Anna Drzazga et al.
CELLS (2020)
The Immune Endocannabinoid System of the Tumor Microenvironment
Melanie Kienzl et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Potential Mechanisms Involved in Palmitoylethanolamide-Induced Vasodepressor Effects in Rats
Bruno A. Marichal-Cancino et al.
JOURNAL OF VASCULAR RESEARCH (2020)
Tumor-induced neurogenesis and immune evasion as targets of innovative anti-cancer therapies
Rodolfo Daniel Cervantes-Villagrana et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
GPR55 deficiency is associated with increased adiposity and impaired insulin signaling in peripheral metabolic tissues
Christopher Lipina et al.
FASEB JOURNAL (2019)
Direct targeting of Gαq and Gα11 oncoproteins in cancer cells
Suvi Annala et al.
SCIENCE SIGNALING (2019)
Potential Metabolic and Behavioural Roles of the Putative Endo-cannabinoid Receptors GPR18, GPR55 and GPR119 in Feeding
Ricardo E. Ramirez-Orozco et al.
CURRENT NEUROPHARMACOLOGY (2019)
Preference for Glucose over Inositol Headgroup during Lysolipid Activation of G Protein-Coupled Receptor 55
Adam T. Guy et al.
ACS CHEMICAL NEUROSCIENCE (2019)
Activation of GPR55 induces neuroprotection of hippocampal neurogenesis and immune responses of neural stem cells following chronic, systemic inflammation
Jeremy D. Hill et al.
BRAIN BEHAVIOR AND IMMUNITY (2019)
G protein-coupled receptor GPR55 promotes colorectal cancer and has opposing effects to cannabinoid receptor 1
Carina Hasenoehrl et al.
INTERNATIONAL JOURNAL OF CANCER (2018)
Possible role of hippocampal GPR55 in spatial learning and memory in rats
Bruno A. Marichal-Cancino et al.
ACTA NEUROBIOLOGIAE EXPERIMENTALIS (2018)
Activation of GPR55 increases neural stem cell proliferation and promotes early adult hippocampal neurogenesis
Jeremy D. Hill et al.
BRITISH JOURNAL OF PHARMACOLOGY (2018)
Endocannabinoid Tone Regulates Human Sebocyte Biology
Nora Zakany et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2018)
Mechanisms of L-alpha-lysophosphatidylinositol-induced relaxation in human pulmonary arteries
Olga Karpinska et al.
LIFE SCIENCES (2018)
The current state and future perspectives of cannabinoids in cancer biology
Pawel Sledzinski et al.
CANCER MEDICINE (2018)
The Epithelial-to-Mesenchymal Transition in Cancer
Joelle Roche
CANCERS (2018)
Anandamide inhibits FcεRI-dependent degranulation and cytokine synthesis in mast cells through CB2 and GPR55 receptor activation. Possible involvement of CB2-GPR55 heteromers
Silvia L. Cruz et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2018)
The LPI/GPR55 axis enhances human breast cancer cell migration via HBXIP and p-MLC signaling
Xiao-lei Zhou et al.
ACTA PHARMACOLOGICA SINICA (2018)
Marked for death: targeting epigenetic changes in cancer
Sophia Xiao Pfister et al.
NATURE REVIEWS DRUG DISCOVERY (2017)
Lysophosphatidylcholine elicits intracellular calcium signaling in a GPR55-dependent manner
Anna Drzazga et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)
Advances in the Physiology of GPR55 in the Central Nervous System
Bruno A. Marichal-Cancino et al.
CURRENT NEUROPHARMACOLOGY (2017)
Palmitoylethanolamide Modulates GPR55 Receptor Signaling in the Ventral Hippocampus to Regulate Mesolimbic Dopamine Activity, Social Interaction, and Memory Processing
Cecilia Kramar et al.
CANNABIS AND CANNABINOID RESEARCH (2017)
GPR55 promotes migration and adhesion of colon cancer cells indicating a role in metastasis
J. Kargl et al.
BRITISH JOURNAL OF PHARMACOLOGY (2016)
Blockade of GPR55 in the dorsolateral striatum impairs performance of rats in a T-maze paradigm
Bruno A. Marichal-Cancino et al.
BEHAVIOURAL PHARMACOLOGY (2016)
Advances Towards The Discovery of GPR55 Ligands
Paula Morales et al.
CURRENT MEDICINAL CHEMISTRY (2016)
Gβγ Pathways in Cell Polarity and Migration Linked to Oncogenic GPCR Signaling: Potential Relevance in Tumor Microenvironment
Jose Vazquez-Prado et al.
MOLECULAR PHARMACOLOGY (2016)
The GPR 55 agonist, L--lysophosphatidylinositol, mediates ovarian carcinoma cell-induced angiogenesis
Nicole A. Hofmann et al.
BRITISH JOURNAL OF PHARMACOLOGY (2015)
Central administration of GPR55 receptor agonist and antagonist modulates anxiety-related behaviors in rats
Abbasali Rahimi et al.
FUNDAMENTAL & CLINICAL PHARMACOLOGY (2015)
Modulation of the tumor microenvironment and inhibition of EGF/EGFR pathway: Novel anti-tumor mechanisms of Cannabidiol in breast cancer
Mohamad Elbaz et al.
MOLECULAR ONCOLOGY (2015)
Glycerophospholipid regulation of modality-specific sensory axon guidance in the spinal cord
Adam T. Guy et al.
SCIENCE (2015)
The therapeutic potential of orphan GPCRs, GPR35 and GPR55
Derek M. Shore et al.
FRONTIERS IN PHARMACOLOGY (2015)
The differential characterization of GPR55 receptor in human peripheral blood reveals a distinctive expression in monocytes and NK cells and a proinflammatory role in these innate cells
Valerio Chiurchiu et al.
INTERNATIONAL IMMUNOLOGY (2015)
Role of GPR55 during Axon Growth and Target Innervation
Hosni Cherif et al.
ENEURO (2015)
Role of Pre-Junctional CB1, But not CB2, TRPV1 or GPR55 Receptors in Anandamide-Induced Inhibition of the Vasodepressor Sensory CGRPergic Outflow in Pithed Rats
Bruno A. Marichal-Cancino et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2014)
CB1 and GPR55 receptors are co-expressed and form heteromers in rat and monkey striatum
E. Martinez-Pinilla et al.
EXPERIMENTAL NEUROLOGY (2014)
Targeting CB2-GPR55 Receptor Heteromers Modulates Cancer Cell Signaling
Estefania Moreno et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Novel lysophosphoplipid receptors: their structure and function
Kumiko Makide et al.
JOURNAL OF LIPID RESEARCH (2014)
GPR55 Deletion in Mice Leads to Age-Related Ventricular Dysfunction and Impaired Adrenoceptor-Mediated Inotropic Responses
Sarah K. Walsh et al.
PLOS ONE (2014)
Analysis of anandamide- and lysophosphatidylinositol-induced inhibition of the vasopressor responses produced by sympathetic stimulation or noradrenaline in pithed rats
Bruno A. Marichal-Cancino et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2013)
The G Protein-Coupled Receptor 55 Ligand L-α-Lysophosphatidylinositol Exerts Microglia-Dependent Neuroprotection After Excitotoxic Lesion
Sonja Kallendrusch et al.
GLIA (2013)
The orphan receptor GPR55 drives skin carcinogenesis and is upregulated in human squamous cell carcinomas
E. Perez-Gomez et al.
ONCOGENE (2013)
The actions and metabolism of lysophosphatidylinositol, an endogenous agonist for GPR55
Atsushi Yamashita et al.
PROSTAGLANDINS & OTHER LIPID MEDIATORS (2013)
The Serine Hydrolase ABHD6 Is a Critical Regulator of the Metabolic Syndrome
Gwynneth Thomas et al.
CELL REPORTS (2013)
A Selective Antagonist Reveals a Potential Role of G Protein-Coupled Receptor 55 in Platelet and Endothelial Cell Function
Julia Kargl et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2013)
Cannabidiol inhibits angiogenesis by multiple mechanisms
M. Solinas et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
A potential role for GPR55 in gastrointestinal functions
Rudolf Schicho et al.
CURRENT OPINION IN PHARMACOLOGY (2012)
The Cannabinoid Receptor CB1 Modulates the Signaling Properties of the Lysophosphatidylinositol Receptor GPR55
Julia Kargl et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
GPR55 regulates cannabinoid 2 receptor-mediated responses in human neutrophils
Nariman A. B. Balenga et al.
CELL RESEARCH (2011)
Pharmacology of GPR55 in Yeast and Identification of GSK494581A as a Mixed-Activity Glycine Transporter Subtype 1 Inhibitor and GPR55 Agonist
Andrew J. Brown et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2011)
Anandamide exerts its antiproliferative actions on cholangiocarcinoma by activation of the GPR55 receptor
Li Huang et al.
LABORATORY INVESTIGATION (2011)
The putative cannabinoid receptor GPR55 promotes cancer cell proliferation
G. Hu et al.
ONCOGENE (2011)
The orphan G protein-coupled receptor GPR55 promotes cancer cell proliferation via ERK
C. Andradas et al.
ONCOGENE (2011)
The putative cannabinoid receptor GPR55 defines a novel autocrine loop in cancer cell proliferation
R. Pineiro et al.
ONCOGENE (2011)
Modulation of the novel cannabinoid receptor-GPR55-during rat fetoplacental development
B. M. Fonseca et al.
PLACENTA (2011)
A role for L-α-lysophosphatidylinositol and GPR55 in the modulation of migration, orientation and polarization of human breast cancer cells
Lesley A. Ford et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
GPR55 ligands promote receptor coupling to multiple signalling pathways
Christopher M. Henstridge et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Lysophosphatidylinositol induces rapid phosphorylation of p38 mitogen-activated protein kinase and activating transcription factor 2 in HEK293 cells expressing GPR55 and IM-9 lymphoblastoid cells
Saori Oka et al.
JOURNAL OF BIOCHEMISTRY (2010)
International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid Receptors and Their Ligands: Beyond CB1 and CB2
R. G. Pertwee et al.
PHARMACOLOGICAL REVIEWS (2010)
CB1 and CB2 cannabinoid receptors differentially regulate the production of reactive oxygen species by macrophages
Ki Hoon Han et al.
CARDIOVASCULAR RESEARCH (2009)
The GPR55 ligand L-alpha-lysophosphatidylinositol promotes RhoA-dependent Ca2+ signaling and NFAT activation
Christopher M. Henstridge et al.
FASEB JOURNAL (2009)
Atypical Responsiveness of the Orphan Receptor GPR55 to Cannabinoid Ligands
Ankur Kapur et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
The enigmatic pharmacology of GPR55
Ruth A. Ross
TRENDS IN PHARMACOLOGICAL SCIENCES (2009)
NFAT proteins: emerging roles in cancer progression
Maria Mancini et al.
NATURE REVIEWS CANCER (2009)
The role of ATF-2 in oncogenesis
Spiros A. Vlahopoulos et al.
BIOESSAYS (2008)
Integrin clustering enables anandamide-induced Ca2+ signaling in endothelial cells via GPR55 by protection against CB1-receptor-triggered repression
Markus Waldeck-Weiermair et al.
JOURNAL OF CELL SCIENCE (2008)
Cannabinoid receptors: Where they are and what they do
K. Mackie
JOURNAL OF NEUROENDOCRINOLOGY (2008)
GPR55 is a cannabinoid receptor that increases intracellular calcium and inhibits M current
Jane E. Lauckner et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
The orphan receptor GPR55 is a novel cannabinoid receptor
E. Ryberg et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
Identification of GPR55 as a lysophosphatidylinositol receptor
Saori Oka et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
Signalling to transcription:: Store-operated Ca2+ entry and NFAT activation in lymphocytes
Yousang Gwack et al.
CELL CALCIUM (2007)
Biologic functions of the G12 subfamily of heterotrimeric G proteins: Growth, migration, and Metastasis
Patrick Kelly et al.
BIOCHEMISTRY (2007)
Opposing actions of endocannabinoids on cholangiocarcinoma growth - Recruitment of Fas and Fas ligand to lipid rafts
Sharon DeMorrow et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Induction of preferential chemotaxis of unstimulated B-lymphocytes by 2-arachidonoylglycerol in immunized mice
Takashi Tanikawa et al.
MICROBIOLOGY AND IMMUNOLOGY (2007)
Overexpression of cannabinoid receptors CB1 and CB2 correlates with improved prognosis of patients with hepatocellular carcinoma
Xundi Xu et al.
CANCER GENETICS AND CYTOGENETICS (2006)
Evolutionary origins of the endocannabinoid system
JM McPartland et al.
GENE (2006)
Paradoxical roles of the immune system during cancer development
KE de Visser et al.
NATURE REVIEWS CANCER (2006)
Cannabinoid receptor homo- and heterodimerization
K Mackie
LIFE SCIENCES (2005)
Δ-9-tetrahydrocannabinol enhances breast cancer growth and metastasis by suppression of the antitumor immune response
RJ McKallip et al.
JOURNAL OF IMMUNOLOGY (2005)
The endogenous cannabinoid 2-arachidonoyl glycerol as in vivo chemoattractant for dendritic cells and adjuvant for Th1 response to a soluble protein
GJM Maestroni
FASEB JOURNAL (2004)
Anandamide is an endogenous inhibitor for the migration of tumor cells and T lymphocytes
J Joseph et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2004)
Identification of human plasma lysophospholipase D, a lysophosphatidic acid-producing enzyme, as autotaxin, a multifunctional phosphodiesterase
A Tokumura et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Autotaxin has lysophospholipase D activity leading to tumor cell growth and motility by lysophosphatidic acid production
M Umezu-Goto et al.
JOURNAL OF CELL BIOLOGY (2002)
International Union of Pharmacology. XXVII. Classification of cannabinoid receptors
AC Howlett et al.
PHARMACOLOGICAL REVIEWS (2002)
Share Paper
